219 related articles for article (PubMed ID: 23500246)
1. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer.
Ylänen K; Poutanen T; Savikurki-Heikkilä P; Rinta-Kiikka I; Eerola A; Vettenranta K
J Am Coll Cardiol; 2013 Apr; 61(14):1539-47. PubMed ID: 23500246
[TBL] [Abstract][Full Text] [Related]
2. Myocardial iron load and fibrosis in long term survivors of childhood leukemia.
Cheung YF; Lam WW; Ip JJ; Cheuk DK; Cheng FW; Yang JY; Yau JP; Ho KK; Li CK; Li RC; Yuen HL; Ling AS; Li VW; Chan GC
Pediatr Blood Cancer; 2015 Apr; 62(4):698-703. PubMed ID: 25557466
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy.
Ylänen K; Eerola A; Vettenranta K; Poutanen T
Am J Cardiol; 2014 Jun; 113(11):1886-92. PubMed ID: 24837269
[TBL] [Abstract][Full Text] [Related]
4. Relation of fragmented QRS complex to right ventricular fibrosis detected by late gadolinium enhancement cardiac magnetic resonance in adults with repaired tetralogy of fallot.
Park SJ; On YK; Kim JS; Park SW; Yang JH; Jun TG; Kang IS; Lee HJ; Choe YH; Huh J
Am J Cardiol; 2012 Jan; 109(1):110-5. PubMed ID: 21962997
[TBL] [Abstract][Full Text] [Related]
5. Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.
Ylänen K; Eerola A; Vettenranta K; Poutanen T
Eur J Pediatr; 2016 Oct; 175(10):1379-86. PubMed ID: 27620626
[TBL] [Abstract][Full Text] [Related]
6. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
7. Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments.
de Ville de Goyet M; Brichard B; Robert A; Renard L; Veyckemans F; Vanhoutte L; Moniotte S
Pediatr Blood Cancer; 2015 May; 62(5):867-74. PubMed ID: 25597617
[TBL] [Abstract][Full Text] [Related]
8. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity.
Nucifora G; Aquaro GD; Pingitore A; Masci PG; Lombardi M
Eur J Heart Fail; 2011 Feb; 13(2):170-6. PubMed ID: 21208941
[TBL] [Abstract][Full Text] [Related]
10. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
11. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness.
Ellims AH; Shaw JA; Stub D; Iles LM; Hare JL; Slavin GS; Kaye DM; Taylor AJ
J Am Coll Cardiol; 2014 Mar; 63(11):1112-8. PubMed ID: 24518490
[TBL] [Abstract][Full Text] [Related]
12. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.
Kwong RY; Chan AK; Brown KA; Chan CW; Reynolds HG; Tsang S; Davis RB
Circulation; 2006 Jun; 113(23):2733-43. PubMed ID: 16754804
[TBL] [Abstract][Full Text] [Related]
13. Association of myocardial fibrosis, B-type natriuretic peptide, and cardiac magnetic resonance parameters of remodeling in chronic ischemic cardiomyopathy.
Henkel DM; Glockner J; Miller WL
Am J Cardiol; 2012 Feb; 109(3):390-4. PubMed ID: 22078219
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes.
La Gerche A; Burns AT; Mooney DJ; Inder WJ; Taylor AJ; Bogaert J; Macisaac AI; Heidbüchel H; Prior DL
Eur Heart J; 2012 Apr; 33(8):998-1006. PubMed ID: 22160404
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic value of right ventricular dysfunction on cardiovascular magnetic resonance imaging in anthracycline-treated cancer survivors.
Chhikara S; Hooks M; Athwal PSS; Hughes A; Ismail MF; Joppa S; Velangi PS; Nijjar PS; Blaes AH; Shenoy C
Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1222-1230. PubMed ID: 34297807
[TBL] [Abstract][Full Text] [Related]
16. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries.
Babu-Narayan SV; Goktekin O; Moon JC; Broberg CS; Pantely GA; Pennell DJ; Gatzoulis MA; Kilner PJ
Circulation; 2005 Apr; 111(16):2091-8. PubMed ID: 15851616
[TBL] [Abstract][Full Text] [Related]
17. Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy.
Doesch C; Dierks DM; Haghi D; Schimpf R; Kuschyk J; Suselbeck T; Schoenberg SO; Borggrefe M; Papavassiliu T
Int J Cardiol; 2014 Dec; 177(2):429-35. PubMed ID: 25304065
[TBL] [Abstract][Full Text] [Related]
18. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
[TBL] [Abstract][Full Text] [Related]
19. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
20. Late characterisation of cardiac effects following anthracycline and trastuzumab treatment in breast cancer patients.
Kimball A; Patil S; Koczwara B; Raman KS; Perry R; Grover S; Selvanayagam J
Int J Cardiol; 2018 Jun; 261():159-161. PubMed ID: 29576422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
